Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech

Translation Insights in Nonclinical Safety Assessment

Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development, BMS

The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization

Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory

New Developments in Ion Mobility-Mass Spectrometry Enabling Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

Johnathan Bauman, Principal Scientist, Pfizer

Accelerating the Delivery of Small Molecule High Resolution Accurate Mass Structure Elucidation Results Through the Use of Thermo Scientific™ Compound Discoverer Software™

Joseph Camardo, Senior Vice President Celgene Global Health and Global Medical Affairs, Celgene

Attention to Neglected Tropical Diseases: The Impact of the Pharmaceutical Industry and the Mission of Celgene Global Health

Andrea Casasola-LaMacchia, Postdoctoral Scientist, Pfizer

Quantitative Biomarkers & Biomeasures BioMedicine Design

Joseph Cornicelli,  Director, In Vivo Cardiovascular and Metabolic Diseases, Integrated Drug Discovery, Charles River Laboratories

Research Models for NASH

Arindam Dasgupta, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA

Common BA/BE Inspection Observations and their Mitigation Strategies

William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego

Antiparasitic Drug Discovery from Marine Cyanobacteria

Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb

Title TBA

Sylvia Janetzki, Founder and President, ZellNet Consulting

Monitoring the Function of Single Immune Cells - How to Tackle this Daunting Task and Apply Cutting-Edge Developments for Obtaining Meaningful Data

Vibha, Jawa, Director Biologics and Vaccine Development, Merck

Current Perspectives on Preclinical Predictive Tools for Immunogenicity Risk Assessment and their Clinical Translation

Sadik Kassim, CSO, Mustang Bio

CART-ography:  Lessons Learned from the Analytical Characterization of the First Two FDA Approved Chimeric Antigen Receptor Therapies

Christopher Kochansky, Research Scientist, Merck

Automated Metabolite Identification for Design Ideation

Ashutosh Kulkarni, Director of Clinical Pharmacology, Nonclinical and Translational Sciences Group, Allergan

ADME Screening Paradigm for Covalent Inhibitor Drugs – Role of Traditional vs Non-Traditional Assays

Xiaomin Liang, Research Scientist, Drug Metabolism, Gilead

Use of In Vitro Tools and Genetic Data to Identify Transporter Endogenous Biomarkers

John O. Link, Vice President, Medicinal Chemistry, Gilead Sciences 

Drug Discovery in "Rulebreaker" Chemical Space: Ledipasvir and Velpatasvir

Holly Maw, Scientist IV, Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals

N-methylation of BI 187004 by thiol-S-methyltransferase

Jun Qu, Professor, Department of Pharmaceutical Sciences, SUNY-Buffalo, Chief Scientist in Bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences

Sensitive and Robust Trapping-Micro-LC-MS for the Quantification of Biomarkers and Antibody Therapeutics

Giovanna Scapin, Principal Scientist, Merck

Insights into the Insulin Receptor Activation: the Cryo-EM Structure of the IR in Complex with Insulin

Keith Sutton, Senior Research Scientist, Charles River Laboratories, UK

When the Cell is the Drug, Challenges for Bioanalysis

Sarah Voytek, Associate Director, Preclinical Development, bluebird bio

Drug Distribution Analysis in the Preclinical Development of Gene and Cell Therapy Products

Debra Luffer-Atlas, Senior Research Fellow, Eli Lilly

An ADME Perspective on DILI Hazard Identification  

Jing-Tao Wu, Vice President DMPK and Investigative Toxicology, Alnylam Pharmaceuticals

Mechanistic ADME of siRNA-GaINAc Conjugates

Yuhong Xiang, Scientist, Pfizer

Development of a Robust Neutralizing Antibody (NAb) Assay with High Drug and Target Tolerance to Support Clinical Development of an anti-TFPI Therapeutic Monoclonal Antibody (mAb)

Ming Yao, Senior Research Scientist, Bristol-Myers Squibb

Fast and Comprehensive Detection and Characterization of Cyclic Peptide Metabolites using Software-Aided Data Processing Tools